NM_001099922.3:c.3143C>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001099922.3(ALG13):​c.3143C>G​(p.Ala1048Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,203,211 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00025 ( 0 hom., 6 hem., cov: 22)
Exomes š‘“: 0.000023 ( 0 hom. 6 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.938

Publications

1 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.034623653).
BP6
Variant X-111757757-C-G is Benign according to our data. Variant chrX-111757757-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 383411.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000252 (28/111243) while in subpopulation AMR AF = 0.0027 (28/10377). AF 95% confidence interval is 0.00192. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.3143C>G p.Ala1048Gly missense_variant Exon 26 of 27 ENST00000394780.8 NP_001093392.1 Q9NP73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.3143C>G p.Ala1048Gly missense_variant Exon 26 of 27 2 NM_001099922.3 ENSP00000378260.3 Q9NP73-1

Frequencies

GnomAD3 genomes
AF:
0.000252
AC:
28
AN:
111243
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00270
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000236
AC:
4
AN:
169590
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000778
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000477
GnomAD4 exome
AF:
0.0000229
AC:
25
AN:
1091968
Hom.:
0
Cov.:
30
AF XY:
0.0000168
AC XY:
6
AN XY:
358082
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26174
American (AMR)
AF:
0.000379
AC:
13
AN:
34264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19055
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30086
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52740
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40431
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4056
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
839325
Other (OTH)
AF:
0.000240
AC:
11
AN:
45837
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000252
AC:
28
AN:
111243
Hom.:
0
Cov.:
22
AF XY:
0.000179
AC XY:
6
AN XY:
33433
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30604
American (AMR)
AF:
0.00270
AC:
28
AN:
10377
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3547
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2645
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5931
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53085
Other (OTH)
AF:
0.00
AC:
0
AN:
1489
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000574
ExAC
AF:
0.0000332
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Sep 14, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 20, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jan 18, 2019
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 36 Benign:1
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.34
T;.;.;.;.
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.61
T;T;.;T;.
M_CAP
Benign
0.0088
T
MetaRNN
Benign
0.035
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;.;.;.;.
PhyloP100
0.94
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.4
N;.;N;.;.
REVEL
Benign
0.024
Sift
Benign
0.15
T;.;T;.;.
Sift4G
Benign
0.17
T;T;T;T;T
Polyphen
0.0010
B;B;B;B;B
Vest4
0.040
MutPred
0.11
Loss of sheet (P = 0.0315);.;.;.;.;
MVP
0.40
MPC
0.18
ClinPred
0.049
T
GERP RS
2.4
Varity_R
0.073
gMVP
0.15
Mutation Taster
=98/2
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773401427; hg19: chrX-111000985; API